Newsletter Subscription

Innovative Medicine Initiative (IMI) – Joint technology Initiative


Thematic task force/working group in EU




IMI's overall goal is to reinvigorate the biopharmaceutical sector in Europe. To reach this objective, a unique collaboration within the pharmaceutical sector will be implemented through the IMI:
For the first time, competitor pharmaceutical companies will collaborate to find solutions in order to overcome the research bottlenecks in the drug development process.

Participating Countries

All EU Member States and Associated countries


IMI is based in Covent Garden, Place Rogier 16, 1210 Brussels Postal mail should be sent to: IMI JU, COV2, Office 14/121, 1049 Brussels Telephone: +32 (0)2-221 81 81 or +32 (0)2-221 81 82 Email: INFODESK@imi.europa.eu

See more

BILAT-USA (Grant Agreement no: 244434) and Link2US (Grant Agreement no: 244371) Projects are co-funded by the European Union’s Capacities Programme on International Cooperation under the 7th Framework Programme for Research and Technological Cooperation.